A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal Cancer

Conditions:   Stage II Esophageal Cancer;   Stage III Esophageal Cancer
Interventions:   Combination Product: Definitive Radiochemotherapy;   Combination Product: Neoadjuvant Radiochemotherapy
Sponsors:   Tianjin Medical University Cancer Institute and Hospital;   Cancer Institute and Hospital, Chinese Academy of Medical Sciences;   Sun Yat-sen University;   Beijing Cancer Hospital
Not yet recruiting

https://ift.tt/2EmU0yR